Viral clearance in hepatitis C (1b) infection: relationship with human leukocyte antigen class II in a homogeneous population.
about
Dendritic Cells in HIV-1 and HCV Infection: Can They Help Win the Battle?Strain-Specific T-Cell Suppression and Protective Immunity in Patients with Chronic Hepatitis C Virus InfectionManaging Occupational Risks for Hepatitis C Transmission in the Health Care SettingThe natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infectionHistological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levelsGenetic variants in the CCR gene cluster and spontaneous viral elimination in hepatitis C-infected patientsInteraction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcomeHuman leukocyte antigen class II associations with hepatitis C virus clearance and virus‐specific CD4 T cell response among Caucasians and African AmericansA comparative review of HLA associations with hepatitis B and C viral infections across global populationsT cell epitope mapping of JC polyoma virus-encoded proteome reveals reduced T cell responses in HLA-DRB1*04:01+ donorsEffect of HLA on hepatitis C virus clearance and persistence in anti-HCV-positive end-stage renal disease patientsSpecific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremiaEffect of immune pressure on hepatitis C virus evolution: insights from a single-source outbreakHost genetic determinants of spontaneous hepatitis C clearance.Role of host genetic factors in the outcome of hepatitis C virus infection.Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infectionLow frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease.Host genetic determinants in hepatitis C virus infection.Novel host genetic variations associated with spontaneous clearance of a single-source outbreak of HCV1b infections.Human leukocyte antigen class II DQB1*0301, DRB1*1101 alleles and spontaneous clearance of hepatitis C virus infection: a meta-analysis.Host and viral factors in the immunopathogenesis of primary hepatitis C virus infection.The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infectionHost genetics in immune-mediated hepatitis C virus clearance.Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe.Protective KIR-HLA interactions for HCV infection in intravenous drug users.Prognostic factors of hepatic decompensation and hepatocellular carcinoma in patients with transfusion-acquired HCV infection.Influence of HLA alleles in response to treatment with pegylated interferon-alpha and ribavirin in patients with chronic hepatitis C.Spontaneous clearance of hepatitis C virus after long-term opiate dependence therapy with buprenorphine.Lack of a strong association between HLA class II, tumour necrosis factor and transporter associated with antigen processing gene polymorphisms and virological response to alpha-interferon treatment in patients with chronic hepatitis C.Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection.Protective effect of HLA-DRB1 11 and predisposition of HLA-C 04 in the development of severe liver damage in Brazilian patients with chronic hepatitis C virus infection.Ethnicity and route of HCV infection can influence the associations of HLA with viral clearance in an ethnically heterogeneous population.Distribution of the human leukocyte antigen class II alleles in Brazilian patients with chronic hepatitis C virus infection.
P2860
Q27010312-D2E235A0-2D61-48A9-B6DB-F47187B40F02Q27469607-33F45AE2-A916-4B44-A018-FB0AD00FC233Q27477626-6780DC16-242F-4CC3-9191-6957575BA6F3Q27477855-6A2A5A47-E12C-4240-B1DA-24BAE2198DA5Q27477959-ACBBCD61-1CB1-4AE0-9827-A8FCBB61A64AQ27478113-2CE07829-5376-4B75-AC9D-DDCB207C2DA6Q27486089-822C1499-12E2-425D-B544-962DCABE91EDQ27489728-DDF4FB22-F9DF-4749-8C39-E843DF8FB886Q28299722-9E7B7CAE-C18A-4462-A4A4-81D867187E41Q28704590-152E780E-E6DE-4E8B-9118-691B83BCC48AQ33796039-A66E03BE-2AE6-446E-90CD-B60E0FC099A0Q34158520-3686AEA9-CDC9-425D-89EE-C4222527A3A4Q34601454-2348FF7F-94FD-4EFA-AAA8-9CCD8428E722Q35011376-C8168BF2-4E9A-4766-8A97-DE722A4263F9Q35259735-80738D20-124A-4CF5-BD01-742578411682Q35350883-587A5C28-5CAC-4AAE-B6DF-2AFD95B713FCQ35363566-EF22C0F5-2B1F-4B40-BA60-49A0DC9BA65EQ35753723-6CEFBAE3-F410-461E-A4F8-7CDFF311D7A5Q35943372-792EE19E-8E3A-4A7A-839B-AD91F12ED5A8Q36497084-3332D6D1-0B12-4374-9F80-C92E6D080935Q36666331-981A5B53-307E-40AF-8B6D-5060EBEF7B2CQ37678136-5D570540-27A4-40FD-A95D-6B00F10D0115Q37862746-79D547CD-F8CC-4954-BF87-8369B441D050Q38454850-57FF6EB1-C52D-4130-911B-A31598D6A305Q41903533-03C3989F-1D16-4799-82CC-54E2225BB41CQ42236954-6DB900BB-F6BF-4D9F-88DC-614D7345254DQ42977154-23B18995-60EC-4661-BD44-C2449B8AE7ACQ42988405-D5A9C7BA-AD26-4AB9-B06C-42BAAE1BBCD3Q42988918-15C63A3D-3288-4923-9D45-5CA6E37E5EE4Q43031795-6F0ED98F-CEE8-4470-B019-2B95405CFF5EQ45356172-AC388CE9-EC1D-4B83-9D02-368EE08712D1Q45357502-B32FF2A9-E48D-4AFA-80D1-027F7A248396Q45389812-DA410492-2270-4FC0-B215-943681B5B7F7
P2860
Viral clearance in hepatitis C (1b) infection: relationship with human leukocyte antigen class II in a homogeneous population.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Viral clearance in hepatitis C ...... I in a homogeneous population.
@en
Viral clearance in hepatitis C
@nl
type
label
Viral clearance in hepatitis C ...... I in a homogeneous population.
@en
Viral clearance in hepatitis C
@nl
prefLabel
Viral clearance in hepatitis C ...... I in a homogeneous population.
@en
Viral clearance in hepatitis C
@nl
P2093
P356
P1433
P1476
Viral clearance in hepatitis C ...... I in a homogeneous population.
@en
P2093
P304
P356
10.1053/JHEP.2000.7437
P407
P577
2000-06-01T00:00:00Z